In summarizing this study, we affirm that our risk assessment model, based on PADGs, specifically APP, THBS1, F13A1, SRC, PPBP, and VCL, presents robust diagnostic capabilities for stroke patients. This evidence concerns the gene SRC and stroke disorder.